+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Azole affinity of sterol 14α-demethylase (CYP51) enzymes from Candida albicans and Homo sapiens



Azole affinity of sterol 14α-demethylase (CYP51) enzymes from Candida albicans and Homo sapiens



Antimicrobial Agents and ChemoTherapy 57(3): 1352-1360



Candida albicans CYP51 (CaCYP51) (Erg11), full-length Homo sapiens CYP51 (HsCYP51), and truncated Δ60HsCYP51 were expressed in Escherichia coli and purified to homogeneity. CaCYP51 and both HsCYP51 enzymes bound lanosterol (K(s), 14 to 18 μM) and catalyzed the 14α-demethylation of lanosterol using Homo sapiens cytochrome P450 reductase and NADPH as redox partners. Both HsCYP51 enzymes bound clotrimazole, itraconazole, and ketoconazole tightly (dissociation constants [K(d)s], 42 to 131 nM) but bound fluconazole (K(d), ~30,500 nM) and voriconazole (K(d), ~2,300 nM) weakly, whereas CaCYP51 bound all five medical azole drugs tightly (K(d)s, 10 to 56 nM). Selectivity for CaCYP51 over HsCYP51 ranged from 2-fold (clotrimazole) to 540-fold (fluconazole) among the medical azoles. In contrast, selectivity for CaCYP51 over Δ60HsCYP51 with agricultural azoles ranged from 3-fold (tebuconazole) to 9-fold (propiconazole). Prothioconazole bound extremely weakly to CaCYP51 and Δ60HsCYP51, producing atypical type I UV-visible difference spectra (K(d)s, 6,100 and 910 nM, respectively), indicating that binding was not accomplished through direct coordination with the heme ferric ion. Prothioconazole-desthio (the intracellular derivative of prothioconazole) bound tightly to both CaCYP51 and Δ60HsCYP51 (K(d), ~40 nM). These differences in binding affinities were reflected in the observed 50% inhibitory concentration (IC(50)) values, which were 9- to 2,000-fold higher for Δ60HsCYP51 than for CaCYP51, with the exception of tebuconazole, which strongly inhibited both CYP51 enzymes. In contrast, prothioconazole weakly inhibited CaCYP51 (IC(50), ~150 μM) and did not significantly inhibit Δ60HsCYP51.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 051738937

Download citation: RISBibTeXText

PMID: 23274672

DOI: 10.1128/aac.02067-12


Related references

Azole Affinity of Sterol 14alpha-Demethylase CYP51 Enzymes from Candida albicans and Homo sapiens. 2013

The Evolution of Azole Resistance in Candida albicans Sterol 14α-Demethylase (CYP51) through Incremental Amino Acid Substitutions. Antimicrobial Agents and ChemoTherapy 2019, 2019

Structural analyses of Candida albicans sterol 14α-demethylase complexed with azole drugs address the molecular basis of azole-mediated inhibition of fungal sterol biosynthesis. Journal of Biological Chemistry 292(16): 6728-6743, 2017

Effects of Y132H and F145L substitutions on the activity, azole resistance and spectral properties of Candida albicans sterol 14-demethylase P450 (CYP51): a live example showing the selection of altered P450 through interaction with environmental compounds. Journal of Biochemistry 137(5): 625-632, 2005

Characteristics of the heterologously expressed human lanosterol 14alpha-demethylase (other names: P45014DM, CYP51, P45051) and inhibition of the purified human and Candida albicans CYP51 with azole antifungal agents. Yeast 15(9): 755-763, 1999

The mechanism of the acyl-carbon bond cleavage reaction catalyzed by recombinant sterol 14a-demethylase of Candida albicans (other names are: lanosterol 14a-demethylase, P-45014DM, and CYP51). The Journal of Biological Chemistry 271: 445-50, 1996

The mechanism of the acyl-carbon bond cleavage reaction catalyzed by recombinant sterol 14 alpha-demethylase of Candida albicans (other names are: lanosterol 14 alpha-demethylase, P-45014DM, and CYP51). Journal of Biological Chemistry 271(21): 12445-12450, 1996

S279 point mutations in Candida albicans Sterol 14-α demethylase (CYP51) reduce in vitro inhibition by fluconazole. Antimicrobial Agents and ChemoTherapy 56(4): 2099-2107, 2012

Point Mutations in Candida albicans Sterol 14-alpha Demethylase CYP51 Reduce In Vitro Inhibition by Fluconazole. 2012

Formation of azole-resistant Candida albicans by mutation of sterol 14-demethylase P450. Antimicrobial Agents and ChemoTherapy 43(5): 1163-1169, 1999

Formation of Azole-Resistant Candida albicans by Mutation of Sterol 14-Demethylase P450. Antimicrobial Agents and Chemotherapy 43(5): 1163-1169, 1999

Cytochrome P -450-dependent 14-sterol demethylase of Candida albicans and its interaction with azole antifungals. Biochemical Society Transactions 19(3): 782-787, 1991

Azole binding properties of Candida albicans sterol 14-alpha demethylase (CaCYP51). Antimicrobial Agents and ChemoTherapy 54(10): 4235-4245, 2011

Inhibition of 14 -sterol demethylase activity in Candida albicans Darlington does not correlate with resistance to azole. Medical Mycology 25(5): 329-333, 1987

Cytochrome P-450-dependent 14 alpha -sterol demethylase of Candida albicans and its interaction with azole antifungals. Biochemical Society Transactions 19(3): 782-787, 1991